Foamix Pharmaceuticals Ltd.
(NASDAQ : FOMX)

( )
FOMX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
JAZZJazz Pharmaceuticals Plc
0.49%125.932.2%$75.69m
ICPTIntercept Pharmaceuticals, Inc.
-0.34%110.8218.6%$71.32m
PRGOPerrigo Co. Plc
0.76%48.976.8%$64.65m
CTLTCatalent Inc
1.06%42.022.4%$44.70m
PTLAPortola Pharmaceuticals, Inc.
3.86%30.967.7%$44.48m
ICLRICON Plc
0.67%145.054.1%$35.20m
UTHRUnited Therapeutics Corporation
0.92%119.6314.4%$32.23m
HZNPHorizon Pharma plc
1.05%23.177.4%$31.02m
MDCOMedicines Company
3.17%24.7721.8%$29.68m
AERIAerie Pharmaceuticals, Inc.
1.66%41.756.9%$28.89m
ENDPEndo International Plc
0.48%10.578.9%$22.99m
PCRXPacira Pharmaceuticals, Inc.
2.52%40.6810.6%$22.24m
MDWDMediWound Ltd.
0.21%4.720.6%$4.99m
TBPHTheravance Biopharma Inc
2.30%27.569.9%$4.43m
SGYPSynergy Pharmaceuticals, Inc.
9.65%0.3126.3%$3.06m

Company Profile

Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.